Pediatrix Medical Group, Inc.
MD
$14.93
$0.050.34%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -7.42% | 1.19% | 0.90% | 0.74% | 0.83% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -7.42% | 1.19% | 0.90% | 0.74% | 0.83% |
| Cost of Revenue | -11.12% | -5.42% | -1.35% | 1.31% | 1.85% |
| Gross Profit | 8.18% | 27.04% | 9.29% | -1.16% | -3.24% |
| SG&A Expenses | -2.65% | 19.77% | 1.25% | -2.50% | 1.93% |
| Depreciation & Amortization | -48.27% | -24.16% | -32.10% | -1.72% | 15.13% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -10.85% | -2.87% | -1.64% | 0.76% | 2.12% |
| Operating Income | 58.81% | 48.82% | 30.23% | 0.55% | -18.87% |
| Income Before Tax | 259.02% | 124.00% | -18.15% | -530.66% | -62.22% |
| Income Tax Expenses | 94.06% | 119.56% | -38.63% | -237.86% | -41.76% |
| Earnings from Continuing Operations | 413.93% | 124.52% | -9.12% | -641.07% | -71.60% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 413.93% | 124.52% | -9.12% | -641.07% | -71.60% |
| EBIT | 58.81% | 48.82% | 30.23% | 0.55% | -18.87% |
| EBITDA | 26.98% | 35.07% | 18.63% | 0.19% | -11.06% |
| EPS Basic | 404.31% | 123.80% | -10.58% | -635.05% | -71.93% |
| Normalized Basic EPS | 108.78% | 59.75% | 39.91% | -1.18% | -22.20% |
| EPS Diluted | 392.81% | 123.80% | -11.23% | -641.18% | -71.35% |
| Normalized Diluted EPS | 107.35% | 59.75% | 39.60% | -0.88% | -22.19% |
| Average Basic Shares Outstanding | 1.90% | 3.02% | 1.63% | 1.13% | 1.18% |
| Average Diluted Shares Outstanding | 2.59% | 3.02% | 1.90% | 0.81% | 1.16% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |